Slideshows Images Quizzes

Copyright © 2018 by RxList Inc. RxList does not provide medical advice, diagnosis or treatment. See additional information.

Emgality vs. Imitrex

Are Emgality and Imitrex the Same Thing?

Emgality (galcanezumab-gnlm) and Imitrex (sumatriptan) are indicated for the preventive treatment of migraine in adults.

Emgality and Imitrex belong to different drug classes. Emgality is a calcitonin-gene related peptide antagonist and Imitrex is a selective serotonin receptor agonist (a "triptan").

Side effects of Emgality that are different from Imitrex include injection site reactions (such as pain, redness, and itching).

Side effects of Imitrex that are different from Emgality include mild headache (not a migraine), chest pan or tightness, pressure or heavy feeling in any part of your body, weakness, feeling hot or cold, dizziness, spinning sensation, drowsiness, nausea, vomiting, drooling, unusual taste in your mouth after using nasal spray, burning/numbness/pain/irritation in your nose or throat after using nasal spray, and flushing (warmth, redness, or tingling under the skin).

Emgality may interact with other drugs.

Imitrex may interact with other migraine headache medicines, medicines to treat depression or a psychiatric disorder, medicines for Parkinson's disease, medicines for serious infections, certain herbal products, stimulants, narcotics, and medicines to prevent nausea and vomiting.

What Are Possible Side Effects of Emgality?

Common side effects of Emgality include:

  • injection site reactions such as pain, redness, and itching

What Are Possible Side Effects of Imitrex?

Common side effects of Imitrex include:

  • mild headache (not a migraine),
  • pain or chest tightness,
  • pressure or heavy feeling in any part of your body,
  • weakness,
  • feeling hot or cold,
  • dizziness,
  • spinning sensation,
  • drowsiness,
  • nausea,
  • vomiting,
  • drooling,
  • unusual taste in your mouth after using nasal spray,
  • burning/numbness/pain/irritation in your nose or throat after using nasal spray, or
  • flushing (warmth, redness, or tingling under the skin).

What Is Emgality?

Emgality (galcanezumab-gnlm) is a calcitonin-gene related peptide antagonist indicated for the preventive treatment of migraine in adults.

What Is Imitrex?

Imitrex (sumatriptan) is a selective serotonin receptor agonist used in oral, intranasal or injectable dosage form to treat migraine headaches. Imitrex is available as a generic drug.

SLIDESHOW

16 Surprising Headache Triggers and Tips for Pain Relief See Slideshow

What Drugs Interact With Emgality?

Emgality may interact with other drugs. Tell your doctor all medications and supplements you use.

What Drugs Interact With Imitrex?

Imitrex may interact with sibutramine (Meridia); monoamine oxidase inhibitors (MAOIs) isocarboxazid (Marplan); selective serotonin reuptake inhibitors, fluoxetine (Prozac) and sertraline (Zoloft), serotonin; norepinephrine reuptake inhibitors, venlafaxine (Effexor)) and duloxetine (Cymbalta); and ergot-containing medications, dihydroergotamine (Migranal) and ergotamine (Methergine).

How Should Emgality Be Taken?

The recommended dosage of Emgality is a 240 mg loading dose (administered as two consecutive injections of 120 mg each), followed by monthly doses of 120 mg.

How Should Imitrex Be Taken?

The maximum single recommended adult dose of Imitrex Injection for the acute treatment of migraine or cluster headache is 6 mg injected subcutaneously. For the treatment of migraine, if side effects are dose limiting, lower doses (1 mg to 5 mg) of Imitrex may be used.

QUESTION

Who suffers more frequently from migraine headaches? See Answer
Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

Reviewed on 9/17/2019
References
Lilly. Emgality Drug Information.

www.emgality.com/?

GSK. Imitrex Product Information.

http://www.imitrex.com
CONTINUE SCROLLING FOR RELATED SLIDESHOW

Health Solutions From Our Sponsors